Cancer patients often have thick blood where platelets stick to tumor cells and shield them from immune detection. Dino Prato, NMD, suggests low-dose aspirin and a product called Napogen could reduce platelet stickiness and help the immune system attack cancer more effectively.
In integrative medicine, we've been talking about thick blood with cancer patients for decades. Hypocoagulation, sticky blood, clotting tendencies, and we've known for years it's linked to inflammation and the spread of cancer. Platelets can stick onto these tumor cells and they can act like bodyguards and help the cancer cells survive and let them hide or evade your immune system. That's why this matters so much. If you could reduce the cloaking or the clotting or the fibrin, you can help your immune system work better against the cancer. A baby aspirin helps reduce the signal production from the platelets and Napogen can help reduce the signal action and the platelet stickiness. So when you combine these two, you can do this biohack in oncology.
